What is the treatment for G6PD deficiency with iron overload and elevated liver enzymes?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 25, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of G6PD Deficiency with Iron Overload and Elevated Liver Enzymes

Therapeutic phlebotomy is the first-line treatment for patients with G6PD deficiency who have iron overload, elevated liver enzymes, and high bilirubin levels. 1

Understanding the Condition

G6PD deficiency is the most common enzymatic disorder of red blood cells, affecting approximately 400 million people worldwide 2. When a patient with G6PD deficiency presents with:

  • High ferritin
  • High iron
  • High iron saturation
  • High bilirubin
  • Elevated AST/ALT

This constellation of findings suggests iron overload with hepatic involvement, which requires prompt treatment to prevent progression to cirrhosis and other complications.

Treatment Algorithm

First-Line Treatment: Therapeutic Phlebotomy

  1. Initial Phlebotomy Protocol:

    • Remove one unit of blood (200-250 mg iron) once or twice weekly as tolerated 1
    • Monitor hematocrit/hemoglobin before each session
    • Do not reduce hematocrit/hemoglobin to <80% of starting value 1
    • Continue until serum ferritin drops to 50-100 μg/L 1
  2. Monitoring During Treatment:

    • Check serum ferritin after every 10-12 phlebotomies (approximately every 3 months) 1
    • Monitor liver enzymes (AST, ALT) and bilirubin regularly
    • As target ferritin (50-100 μg/L) is approached, test more frequently to avoid iron deficiency 1
  3. Maintenance Phase:

    • After achieving target ferritin levels, assess need for maintenance phlebotomy
    • Frequency varies among individuals (monthly to 1-2 units per year) 1

Special Considerations for G6PD Deficiency

  1. Avoid Oxidative Stressors:

    • Strictly avoid medications that can trigger hemolysis in G6PD deficiency, including:
      • Methylene blue (contraindicated) 1
      • Dapsone
      • Nitrofurantoin
      • Phenazopyridine
      • Primaquine
      • Rasburicase 3
  2. Dietary Modifications:

    • Avoid fava beans, which are a common trigger for hemolysis 4
    • Avoid iron supplements and vitamin C supplements during treatment 1
  3. Monitoring for Hemolysis:

    • Watch for signs of acute hemolysis: darkening of urine, pallor, fatigue, jaundice
    • If hemolysis occurs, discontinue any potential triggers immediately

Management of Complications

If Acute Hemolysis Develops:

  1. Immediately discontinue any potential triggering agents
  2. Provide supportive care with intravenous hydration
  3. Monitor hemoglobin levels closely
  4. Consider plasmapheresis for severe hemolysis with unknown trigger 5
  5. Blood transfusion may be required for severe anemia

For Persistent Iron Overload Despite Phlebotomy:

In patients who cannot tolerate phlebotomy or have persistent iron overload:

  • Consider iron chelation therapy with deferasirox (oral) 6
  • Starting dose based on liver iron concentration (LIC)
  • Monitor for side effects and efficacy with regular ferritin and LIC measurements 6

Expected Outcomes

With appropriate treatment, patients can expect:

  • Reduction of tissue iron stores to normal levels
  • Normalization of elevated liver enzymes
  • Reduction in bilirubin levels
  • Improved sense of well-being and energy levels
  • Reduction in skin pigmentation
  • Potential reversal of hepatic fibrosis (in approximately 30% of cases) 1

Important Caveats

  1. Phlebotomy in G6PD Deficiency:

    • While phlebotomy is generally safe in G6PD deficiency, monitor closely for signs of hemolysis
    • Consider smaller volume phlebotomy if patient shows signs of hemolysis
  2. Cirrhosis Risk:

    • If cirrhosis has already developed, it will not be reversed with iron removal 1
    • Patients with cirrhosis should continue to be screened for hepatocellular carcinoma even after adequate phlebotomy 1
  3. Medication Safety:

    • Document G6PD status prominently in medical records
    • Establish a monitoring protocol for high-risk situations 4
    • Safe medications include benzodiazepines, codeine/derivatives, propofol, fentanyl, and ketamine 7

By following this treatment approach, patients with G6PD deficiency and iron overload can achieve significant improvement in their condition and prevent progression to more serious complications.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Malaria Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Interesting case of G6PD deficiency anemia with severe hemolysis.

Asian journal of transfusion science, 2013

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.